Dermala Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Dermala Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11090
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Dermala Inc (Dermala) is a healthcare products manufacturer that offers skin care products. The company offers acne treatment products such as zinc, acne spot treatment, acne pimple patches, advanced probiotics, acne treatment pads, and acne treatment system. It uses the human microbiome and metabolome to develop treatments for chronic skin diseases. The company spans its expertise in genomics, human skin microbiome, dermatology, bioinformatics, immunology, microbiology, infectious diseases and drug development. It markets its products across the US. Dermala is headquartered in San Diego, California, the US.

Dermala Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Dermala Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Dermala Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Dermala Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Dermala Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Dermala Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Dermala Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Dermala Raises USD1 Million in Venture Financing 10
Partnerships 11
Johnson & Johnson Innovation, Johnson & Johnson Consumer Enter into Partnership with Dermala 11
Licensing Agreements 12
Dermala Enters into Licensing Agreement with Regents of the University of California 12
Dermala Inc – Key Competitors 13
Dermala Inc – Key Employees 14
Dermala Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Dermala Inc, Pharmaceuticals & Healthcare, Key Facts 2
Dermala Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Dermala Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Dermala Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Dermala Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Dermala Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Dermala Raises USD1 Million in Venture Financing 10
Johnson & Johnson Innovation, Johnson & Johnson Consumer Enter into Partnership with Dermala 11
Dermala Enters into Licensing Agreement with Regents of the University of California 12
Dermala Inc, Key Competitors 13
Dermala Inc, Key Employees 14

List of Figures
Dermala Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Dermala Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Dermala Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Dermala Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Dermala Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Dermala Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Dermala Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Dermala Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Dermala Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • New Zealand Pharmaceuticals Ltd:企業の戦略的SWOT分析
    New Zealand Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Celtaxsys Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Celtaxsys Inc (Celtaxsys) is a clinical-stage pharmaceutical development company that develops novel foundational therapies to treat inflammation in rare, orphan designated diseases. Oral once daily acebilustat, the company’s flagship drug candidate under phase 2 clinical trial, is intended …
  • Misr Hotels Co:企業の戦略・SWOT・財務分析
    Misr Hotels Co - Strategy, SWOT and Corporate Finance Report Summary Misr Hotels Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • H.I.S. Co., Ltd.:企業の戦略・SWOT・財務情報
    H.I.S. Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary H.I.S. Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Amathus Public Ltd:企業の戦略・SWOT・財務情報
    Amathus Public Ltd - Strategy, SWOT and Corporate Finance Report Summary Amathus Public Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • PT Kimia Farma (Persero) Tbk (KAEF):製薬・医療:M&Aディール及び事業提携情報
    Summary PT Kimia Farma (Persero) Tbk (Kimia Farma) manufactures, commercializes and distributes pharmaceutical products. The company provides ethical (prescription), generic and other products. It offers products in various categories including alimentary system, allergy and immune system, system an …
  • GIZEH Raucherbedarf GmbH:企業の戦略的SWOT分析
    GIZEH Raucherbedarf GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • MannKind Corp (MNKD):企業の財務・戦略的SWOT分析
    MannKind Corp (MNKD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • The Charles Schwab Corporation:戦略・SWOT・企業財務分析
    The Charles Schwab Corporation - Strategy, SWOT and Corporate Finance Report Summary The Charles Schwab Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • ADAMA Agricultural Solutions Ltd.:企業の戦略的SWOT分析
    ADAMA Agricultural Solutions Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • PharmaCyte Biotech Inc (PMCB)-医療機器分野:企業M&A・提携分析
    Summary PharmaCyte Biotech Inc (PharmaCyte), formerly Nuvilex Inc is a clinical stage biotechnology company that develops and commercializes treatments for cancer and diabetes. The company’s technology is used for the treatment of advanced and inoperable pancreatic cancer, and diabetes. It develops …
  • ImmusanT Inc-製薬・医療分野:企業M&A・提携分析
    Summary ImmusanT Inc (ImmusanT) is a drug company that discovers and develops therapies for celiac disease. The company’s pipeline products include Nexvax 2 and Nexvax 3. Its pipeline product Nexvax 2 is used for treating, preventing and diagnosing celiac disease. ImmusanT’s pipeline products are al …
  • Atomic Energy of Canada Ltd:企業の戦略的SWOT分析
    Atomic Energy of Canada Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Hartford HealthCare Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Hartford HealthCare Corp (HHC) is a healthcare service provider that offers clinical care, education and research services. The organization's services include behavioral and mental health, bone and joint care, cancer, cardiology and heart care, dermatology, diabetes and endocrinology, diges …
  • Minnkota Power Cooperative Inc:発電所・企業SWOT分析
    Minnkota Power Cooperative Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on ke …
  • China Non-ferrous Metal Industry’s Foreign Engineering and Construction Co Ltd:企業の戦略・SWOT・財務分析
    China Non-ferrous Metal Industry's Foreign Engineering and Construction Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Non-ferrous Metal Industry's Foreign Engineering and Construction Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data …
  • Innate Pharma SA (IPH):企業の財務・戦略的SWOT分析
    Summary Innate Pharma SA (Innate Pharma) is a biotechnology company developing antibodies to treat cancer by harnessing the immune system. It offers Lumoxiti, a CD22-directed immunotoxin for the treatment of relapsed or refractory hairy cell leukemia (HCL). The company is investigating drugs against …
  • Linde Malaysia Sdn Bhd:企業の戦略的SWOT分析
    Linde Malaysia Sdn Bhd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • SeaWorld Entertainment, Inc.:企業の戦略・SWOT・財務情報
    SeaWorld Entertainment, Inc. - Strategy, SWOT and Corporate Finance Report Summary SeaWorld Entertainment, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Addnode Group AB (ANOD B):企業の財務・戦略的SWOT分析
    Summary Addnode Group AB (Addnode) is an information technology company that supplies software and services for construction, design, and product data information. The company's solutions include design management solutions, process management solutions, and product lifecycle management solutions, a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆